Previous 10 | Next 10 |
Corbus Pharmaceuticals to Present at the Oppenheimer 32nd Annual Healthcare Conference - Fireside chat with live video webcast on Thursday, March 17th at 8:00 AM ET PR Newswire NORWOOD, Mass. , March 11, 2022 /PRNewswire/ -- Corbus Pharmaceuticals Holdin...
Corbus Pharmaceuticals press release (NASDAQ:CRBP): FY GAAP EPS of -$0.37 beats by $0.03. Revenue of $0.88M (-77.8% Y/Y) beats by $0.04M. As of December 31, 2021, the Company has $98.3 million of cash and investments on hand Shares +3.15% PM. For further details see: Corbus P...
Corbus Pharmaceuticals Reports Fourth Quarter and Year-End 2021 Financial Results and Provides Corporate Updates - Company is advancing its integrin program and on schedule for initiating clinical studies in 2023 - Expanding immuno-oncology pipeline through strategic transac...
NEW YORK and LONDON, March 02, 2022 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), a late-stage biopharmaceutical company focused on innovative therapeutics to treat orphan autoimmune and inflammatory diseases where complement (C5) and/or leukotriene (LBT4) systems...
- Access the event and schedule of presenting companies at virtualinvestorco.com - - Live video webcast presentations of participating companies followed by interactive Q&A session - PITTSTOWN, NJ / ACCESSWIRE / January 12, 2022 / JTC Team ("JTC"), a fully integrate...
Corbus Pharmaceuticals Appoints Rachael Brake, Ph.D., as Chief Scientific Officer - Dr. Brake formerly held leadership roles at Takeda Oncology, including Vice President, Global Project Leader in the Oncology Therapeutic Area and Head, U.S. Medical Affairs, Oncology Business Uni...
Last week was mixed for the penny stocks and higher-priced ones alike. While there were plenty of trends to follow, some continued gaining steam heading into the middle of November. Sure, you’ve got things like metaverse stocks, short squeeze penny stocks , and your typical low f...
Corbus Pharmaceuticals (NASDAQ:CRBP): Q3 GAAP EPS of -$0.02 beats by $0.10. Revenue of $0.1M (-91.9% Y/Y) misses by $0.43M. Press Release As of September 30, 2021, the company has $108M of cash and investments on hand which is expected to fund operations into the first quarter of 2024, based ...
Corbus Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Corporate Updates - Company continues to advance integrin program from preclinical development toward the clinic - Expanding pipeline through strategic transactions remains key priority - Ca...
Corbus Pharmaceuticals to Present at the Jefferies London Healthcare Conference - Fireside chat webcast will be available beginning on Thursday, November 18th at 8:00 AM GMT (3:00 AM ET) PR Newswire NORWOOD, Mass. , Nov. 11, 2021 /PRNewswire/ -- Corbus Pharma...
News, Short Squeeze, Breakout and More Instantly...
Corbus Pharmaceuticals Holdings Inc. Company Name:
CRBP Stock Symbol:
NASDAQ Market:
Corbus Pharmaceuticals Holdings Inc. Website:
A look at the top 10 most actives in the United States Serve Robotics Inc. (SERV) rose 187.1% to $7.55 on volume of 255,453,115 shares 60 Degrees Pharmaceuticals Inc. (SXTP) rose 10.2% to $0.271 on volume of 224,640,171 shares NVIDIA Corporation (NVDA) fell 2.6% to $117.93 on volume of 21...
A look at the top 10 most actives in the United States 60 Degrees Pharmaceuticals Inc. (SXTP) rose 98.3% to $0.4878 on volume of 116,444,604 shares NVIDIA Corporation (NVDA) fell 0.2% to $120.8 on volume of 26,900,560 shares Serve Robotics Inc. (SERV) rose 61.2% to $4.2399 on volume of 25...
2024-07-16 13:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...